When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center.
Where a woman goes for breast cancer treatment can vary widely – ranging from small private practices to large hospital settings. That choice can impact the type of care a woman receives when it comes to reconstruction.
“Breast reconstruction is a very complex treatment issue that requires a lot of discussion. Our results suggest that discussion can be quite different depending on where a patient gets initial treatment,” says lead study author Steven J. Katz, M.D., M.P.H., professor of internal medicine at the U-M Medical School and of health management and policy at the U-M School of Public Health.
“Patients with similar characteristics or preferences may get a different story from different surgeons – and this depends largely on whether a plastic surgeon is on the treatment decision team from the get-go. Plastic surgeons are the ones with the expertise to explain the increasingly complicated procedure options,” Katz adds.
Results of the study appear online in the journal Medical Care and will be published in the October issue.
Researchers from the Cancer Surveillance and Outcomes Research Team, a multidisciplinary collaboration among five centers across the country, surveyed breast cancer patients and their surgeons about treatment choices.
They found that use of mastectomy over breast-conserving lumpectomy varied little by surgeon. Primarily, women who were not eligible for lumpectomy or who preferred mastectomy received the more aggressive surgery. This supports previous research by the CanSORT team that shows surgeons generally are consistent in their approach to mastectomy use.
Reconstruction is another story. About one-third of women who undergo mastectomy go on to have breast reconstruction. While there are multiple reasons why a woman might not have reconstruction, this study found that 31 percent of the variation could be attributed solely to how often the patient’s surgeon talked to a plastic surgeon prior to initial surgery.
“This is a deeply intimate and important decision that women have to make. It should be made with the right information about reconstruction options in consultation with a plastic surgeon involved up front in the treatment planning,” says Katz, co-director of the socio-behavioral program at the U-M Comprehensive Cancer Center.
“Patients should be particularly attentive to engaging their surgeons on the first visit about this important treatment option.”
Methodology: Researchers surveyed 1,780 women diagnosed with breast cancer in the Los Angeles and Detroit metropolitan areas, and matched them to 291 surgeons. Patients were identified from the Surveillance, Epidemiology and End Results registry.
Breast cancer statistics: 209,060 Americans will be diagnosed with breast cancer this year and 40,230 will die from the disease, according to the American Cancer Society
Additional authors: From U-M: Sarah T. Hawley, Ph.D., M.P.H.; Paul Abrahamse, M.A., Christopher R. Friese, R.N., Ph.D.; Amy K. Alderman, M.D., M.P.H.; Jennifer J. Griggs, M.D., M.P.H.; and Timothy P. Hofer, M.D., M.Sc.; from Memorial Sloan-Kettering Cancer Center: Monica Morrow, M.D.; from University of Southern California: Ann Hamilton, Ph.D., M.A.; and from Robert Wood Johnson Medical School: John J. Graff, Ph.D., M.S.
Funding: National Cancer Institute
Reference: Medical Care, Vol. 48, No. 10, October 2010, published online Aug. 28, 2010
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center
Cancer Surveillance & Outcomes Research Team
Clinical trials at U-M